ACAD ACADIA Pharmaceuticals Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 5, 2026
$19.95
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$19.5952w निम्न
$30.9652w उच्च
मार्केट कैप (MRQ)
$3.43B
P/E (TTM)
8.9
EPS (TTM)
$2.23
राजस्व (TTM)
$1.14B
आपके बैज
52W रेंज
$20–$31
विश्लेषक रेटिंग
BUY
मूल्य लक्ष्य
$32
P/E
8.9
ROE
35.7%
शुद्ध लाभ मार्जिन
33.4%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
ACAD स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$19.95
मार्केट कैप (MRQ)
$3.43B
P/E (TTM)
8.9
EPS (TTM)
$2.23
राजस्व (TTM)
$1.14B
ROE (TTM)
35.7%
52W रेंज
$20–$31
ACAD स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
ACADIA Pharmaceuticals Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Product development
Nuplazid, a drug developed by Acadia in the late 1990s, "was designed to stimulate a subset of the brain’s serotonin receptors, or the proteins that govern memory, cognition and learning." On April 29, 2016, the FDA approved Acadia's drug, Nuplazid, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. Nuplazid is the trade name for Acadia's proprietary molecule, pimavanserin, a selective serotonin inverse agonist preferentially targeting 5-HT2a receptors. Acadia had partnered with Biovail in the late-stage clinical testing of the drug, which showed trial failures as of 2009.
Acadia is running multiple Phase 2 and Phase 3 trials with pimavanserin in several central nervous system conditions: dementia-related psychosis, major depressive disorder, schizophrenia inadequate response, and schizophrenia negative symptoms.
As of 1997, Acadia was among several companies that licensed compounds from Genzyme's small-molecule compound library.
In 2023, the FDA approved trofinetide (marketed as Daybue) for use in Rett syndrome.
History
Acadia started in 1993 as Receptor Technologies, based in Winooski, Vermont. In 1997, the company relocated all operations and management from Vermont to San Diego, California, as a strategic move to garner partnerships with other biotechnology companies. However, the company also had an office in Denmark, in which it received a crucial part of its early investments from BankInvest, under managing director Florian Schönharting, Kommunernes Pensionsforsikring A/S and Dansk Kapitalanlæg Aktieselskab as well as private investor Lars Christiansen. At the time, the company had fifty employees, fourteen of whom were in the Denmark office. The focus of the company in its early years was on genetic screens for receptors, aiming to accelerate early stage drug discovery.
The company planned to conduct an initial public offering (IPO) consisting of 31.6% of the company in 2001, with the intention of raising US$64 million and listing on the NASDAQ exchange under the symbol ACAD. At the time, Acadia and Allergan were collaborating on development of a treatment for glaucoma, and Allergan would retain a 6.3% ownership stake in Acadia after the IPO. However, the company's IPO, which ultimately took place in May 2004, did not fare as well as expected and netted only US$35 million. At the time, the company had five drugs in development and was running two in human trials. The company had a subsequent round of stock offering in May 2007 which raised US$102 million.
In September 2020, Acadia Pharmaceuticals acquired clinical-stage biotechnology company CerSci Therapeutics.
Corporate governance
In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.
== References ==
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगBiotechnology
कर्मचारी796
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$1.07B2016-12-31 → 2025-12-31
EPS$2.302020-12-31 → 2025-12-31
फ्री कैश फ्लो$105M2016-12-31 → 2025-12-31
शुद्ध मार्जिन33.4%2016-12-31 → 2025-12-31
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | ACAD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | 8.95Y औसत ≈-18.7 | ≈-18.7 | 13.8 | अल्पमूल्यित | |
| P/S (TTM) | 3.05Y औसत ≈5.5 | ≈5.5 | 11.9 | अल्पमूल्यित | |
| P/B (MRQ) | 2.65Y औसत ≈6.6 | ≈6.6 | 3.4 | अल्पमूल्यित | |
| मूल्य / FCF (TTM) | 23.65Y औसत ≈64.0 | ≈64.0 | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | 21.45Y औसत ≈63.4 | ≈63.4 | · | · | |
| मूल्य / मूर्त पुस्तक (MRQ) | 2.95Y औसत ≈7.3 | ≈7.3 | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | ACAD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | 7.6%5Y औसत ≈-10.9% | ≈-10.9% | 12.5% | अनुरूप | |
| EBITDA Margin (EBITDA मार्जिन) | 9.8%5Y औसत ≈-10.9% | ≈-10.9% | 12.5% | अनुरूप | |
| प्रीटैक्स मार्जिन (TTM) | 10.7%5Y औसत ≈-8.6% | ≈-8.6% | 16.4% | अनुरूप | |
| शुद्ध लाभ मार्जिन (TTM) | 33.4%5Y औसत ≈-4.9% | ≈-4.9% | 10.2% | अनुरूप | |
| ROA (TTM) | 25.6%5Y औसत ≈-2.7% | ≈-2.7% | -7.4% | शीर्ष स्तर | |
| ROE (TTM) | 35.7%5Y औसत ≈-5.1% | ≈-5.1% | -10.7% | शीर्ष स्तर | |
| ROIC | 24.0%5Y औसत ≈-11.4% | ≈-11.4% | -3.0% | शीर्ष स्तर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | ACAD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| वर्तमान अनुपात (MRQ) | 3.45Y औसत ≈3.8 | ≈3.8 | 6.5 | कम तरलता | |
| Quick Ratio (त्वरित अनुपात) | 1.15Y औसत ≈1.4 | ≈1.4 | 5.0 | कम तरलता |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | ACAD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 11.9%5Y औसत ≈20.1% | ≈20.1% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 27.5%5Y औसत ≈23.7% | ≈23.7% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 19.4% | · | · | · | |
| EPS YoY | 69.1% | · | · | · | |
| Net Income YoY (शुद्ध आय YoY) | 72.7% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | ACAD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.85Y औसत ≈0.9 | ≈0.9 | 0.4 | शीर्ष स्तर | |
| Inventory Turnover (इन्वेंटरी टर्नओवर) | 0.95Y औसत ≈1.1 | ≈1.1 | · | · | |
| Receivables Turnover (प्राप्य टर्नओवर) | 9.75Y औसत ≈9.1 | ≈9.1 | 10.5 | अनुरूप | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$1.3M | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
228.8%
अगली रिपोर्ट
नव 03, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | अग 11, 2026 | $0.18 | $0.06 | 207.2% |
| 31 मार्च 2026 | मई 13, 2026 | $0.02 | $0.06 | -68.4% |
| 31 दिसमबर 2025 | $1.60 | $0.14 | 1044.5% | |
| 30 सितमबर 2025 | $0.42 | $0.15 | 178.1% | |
| 30 जून 2025 | $0.16 | $0.14 | 14.4% | |
| 31 मार्च 2025 | $0.11 | $0.11 | -3.2% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Cost of Revenue | $89M | $82M | $42M | $10M | $19M | $10M | $11M | $12M | $9M | $3M | · | · | |
| Gross Profit | · | · | $685M | $507M | $473M | $432M | $328M | $211M | $116M | $14M | · | · | |
| R&D Expense | $329M | $303M | $352M | $362M | $239M | $319M | $240M | $187M | $149M | $99M | $74M | $61M | |
| SG&A Expense | $549M | $488M | $407M | $369M | $396M | $389M | $326M | $266M | $255M | $186M | $88M | $33M | |
| Operating Expenses | $967M | $727M | $800M | $741M | $655M | $728M | $586M | $471M | $417M | $290M | $165M | $93M | |
| Operating Income | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M | |
| Other Non-op | $2M | $2M | $5M | $4M | $2M | $-997.0K | $997.0K | $-2M | · | · | · | · | |
| Pretax Income | $139M | $258M | $-51M | $-213M | $-168M | $-281M | $-234M | $-244M | $-288M | $-270M | $-164M | $-92M | |
| Income Tax | $-252M | $32M | $10M | $3M | $351.0K | $611.0K | $876.0K | $1M | $1M | $1M | $330.0K | $0 | |
| Net Income | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| EPS (Basic) | $2.32 | $1.37 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| EPS (Diluted) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| Shares (Basic) | 168,356,000 | 165,717,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| Shares (Diluted) | 169,919,000 | 166,362,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| EBITDA | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $178M | $320M | $189M | $115M | $147M | $326M | $190M | $135M | $69M | $164M | $102M | $62M | |
| Receivables | $121M | $99M | $98M | $62M | $64M | $48M | $36M | $26M | $17M | $6M | · | · | |
| Inventory | $111M | $92M | $40M | $12M | $14M | $10M | $6M | $4M | $5M | $4M | · | · | |
| Prepaid Expense | $60M | $56M | $39M | $21M | $24M | $26M | $19M | $21M | $8M | $8M | $2M | $1M | |
| Current Assets | $1.06B | $938M | $616M | $508M | $618M | $718M | $760M | $526M | $373M | $548M | $219M | $325M | |
| PP&E (Net) | $8M | $4M | $5M | $6M | $8M | $9M | $3M | $3M | $3M | $3M | $2M | $553.0K | |
| PP&E (Gross) | $17M | $14M | $14M | $14M | $14M | $13M | $9M | $8M | $7M | $6M | $5M | $3M | |
| Accum. Depreciation | $9M | $10M | $10M | $8M | $6M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Intangibles | $109M | $120M | $65M | $0 | $0 | $1M | $3M | $4M | $6M | $7M | · | · | |
| Other Non-current Assets | $4M | $359.0K | $476.0K | $8M | $4M | $2M | $3M | $2M | $354.0K | $785.0K | $329.0K | $287.0K | |
| Total Assets | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Accounts Payable | $11M | $16M | $18M | $13M | $7M | $8M | $7M | $3M | $9M | $4M | $2M | $2M | |
| Accrued Liabilities | $266M | $379M | $237M | $113M | $89M | $97M | $68M | $56M | $40M | $36M | $20M | $14M | |
| Current Liabilities | $277M | $395M | $254M | $126M | $96M | $106M | $75M | $60M | $49M | $43M | $22M | $16M | |
| Capital Leases | $41M | $42M | $48M | $53M | $56M | $44M | $6M | · | · | · | · | · | |
| Deferred Tax | $11M | $11M | $12M | $13M | $14M | $13M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | $19M | $18M | $15M | $9M | $7M | $5M | $3M | $2M | · | · | · | · | |
| Total Liabilities | $337M | $455M | $317M | $187M | $159M | $156M | $84M | $61M | $49M | $43M | $22M | $16M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $15.0K | $14.0K | $12.0K | $12.0K | $10.0K | $10.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $1.45B | $862M | $808M | |
| Retained Earnings | $-1.81B | $-2.20B | $-2.43B | $-2.37B | $-2.15B | $-1.99B | $-1.70B | $-1.47B | $-1.22B | $-934M | $-663M | $-498M | |
| AOCI | $1M | $292.0K | $24.0K | $-975.0K | $-192.0K | $36.0K | $297.0K | $-372.0K | $-399.0K | $106.0K | $11.0K | $-9.0K | |
| Stockholders' Equity | $1.23B | $733M | $432M | $400M | $541M | $627M | $699M | $479M | $335M | $518M | $200M | $309M | |
| Liabilities + Equity | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Shares Outstanding | 170,309,376 | 166,708,856 | 164,650,219 | 162,064,872 | 161,012,695 | 159,637,771 | 155,275,300 | 143,853,597 | 124,410,552 | 121,367,169 | 101,938,702 | 100,047,331 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $206.0K | |
| Stock-based Comp | $52M | $67M | $66M | $68M | $64M | $84M | $82M | $82M | $76M | $55M | $40M | $16M | |
| Deferred Tax | $-250M | $0 | $0 | $3M | $351.0K | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $11M | $15M | $4M | $0 | $1M | $1M | $1M | $1M | $1M | $985.0K | $0 | $0 | |
| Operating Cash Flow | $110M | $158M | $17M | $-114M | $-126M | $-136M | $-151M | $-167M | $-218M | $-208M | $-122M | $-66M | |
| CapEx | $5M | $523.0K | $50.0K | $0 | $1M | $8M | $1M | $2M | $812.0K | $2M | $2M | $180.0K | |
| Investing Cash Flow | $-303M | $-31M | $32M | $73M | $-71M | $193M | $-166M | $-71M | $92M | $-262M | · | · | |
| Stock Issued | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Net Stock Activity | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Financing Cash Flow | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $534M | · | · | |
| Net Change in Cash | $-143M | $134M | $74M | $-33M | $-179M | $137M | $55M | $68M | $-94M | $63M | $40M | $50M | |
| Taxes Paid | $25M | $20M | $6M | $2M | $1M | $1M | $2M | $1M | $1M | $-365.0K | $415.0K | · | |
| Free Cash Flow | $105M | $157M | $17M | $-114M | $-127M | $-144M | $-152M | $-170M | $-219M | $-212M | $-124M | $-67M |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 94.3% | 98.0% | 97.8% | 97.7% | 96.7% | 94.5% | 92.7% | 82.2% | · | · | |
| Operating Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| Net Margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% | -63.7% | -69.4% | -109.6% | -231.7% | -1565.9% | -269578.7% | -77062.5% | |
| Pretax Margin | 13.0% | 26.9% | -7.0% | -41.3% | -34.6% | -63.6% | -69.1% | -109.0% | -230.8% | -1558.2% | -269037.7% | · | |
| EBITDA Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| ROA | 28.4% | 23.4% | -9.2% | -33.5% | -22.6% | -36.0% | -35.5% | -53.0% | -61.2% | -69.3% | -60.1% | -35.9% | |
| ROE | 38.1% | 34.6% | -15.4% | -52.3% | -30.3% | -43.9% | -33.9% | -69.8% | -67.8% | -75.6% | -64.6% | -37.6% | |
| ROIC | 24.0% | 27.6% | -20.4% | -56.5% | -31.6% | -45.8% | -35.4% | -51.9% | -87.5% | -52.9% | -82.6% | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 | 6.8 | 10.2 | 8.8 | 7.6 | 12.9 | 10.0 | 20.5 | |
| Quick Ratio | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 | 3.5 | 3.0 | 2.7 | 1.8 | 4.0 | 4.7 | 3.9 |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.0 | 1.1 | 0.8 | 0.7 | 0.6 | 0.5 | 0.5 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.9 | 1.2 | 1.6 | 0.8 | 0.9 | 1.3 | 2.2 | · | 1.9 | 1.5 | · | · | |
| Receivables Turnover | 9.7 | 9.7 | 9.1 | 8.2 | 8.6 | 10.5 | 11.0 | 10.3 | 10.7 | 5.9 | · | · |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.21 | $4.40 | $2.62 | $2.47 | $3.36 | $3.93 | $4.50 | $3.33 | $2.69 | $4.27 | $1.96 | $3.09 | |
| Revenue / Share | $6.31 | $5.76 | $4434.39 | $3199.07 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.65 | $0.95 | $101.95 | $-705.30 | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.04 | $1.92 | $1.15 | $0.71 | $0.92 | $2.04 | $1.22 | $0.94 | $0.56 | $1.35 | $1.00 | $0.62 | |
| EPS (TTM) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.9% | 31.9% | 40.5% | 6.8% | 9.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.5% | 25.5% | 18.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 69.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 72.7% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Net Income TTM | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| Market Cap | $4.55B | $3.06B | $5.16B | $2.58B | $3.76B | $8.53B | $6.64B | $2.33B | $3.75B | $3.50B | $3.63B | $3.18B | |
| P/E | 11.6 | 13.5 | -84.6 | -11.9 | -22.2 | -29.9 | · | · | · | · | · | · | |
| P/S | 4.2 | 3.2 | 7.1 | 5.0 | 7.8 | 19.3 | 19.6 | 10.4 | 30.0 | 202.0 | 59575.7 | 26470.9 | |
| P/B | 3.7 | 4.2 | 11.9 | 6.4 | 6.9 | 13.6 | 9.5 | 4.9 | 11.2 | 6.8 | 18.2 | 10.3 | |
| P / Tangible Book | 4.1 | 5.0 | 14.1 | 6.4 | 6.9 | 13.6 | · | · | · | · | · | · | |
| P / Cash Flow | 41.4 | 19.4 | 308.7 | -22.6 | -29.9 | -62.7 | -44.0 | -13.9 | -17.2 | -16.6 | -29.8 | -47.8 | |
| P / FCF | 43.3 | 19.5 | 309.6 | -22.6 | -29.6 | -59.4 | -43.6 | -13.7 | -17.1 | -16.5 | -29.3 | -47.7 | |
| Earnings Yield | 8.6% | 7.4% | -1.2% | -8.4% | -4.5% | -3.4% | · | · | · | · | · | · |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $308M | $268M | $284M | $279M | $265M | $244M | $260M | $250M | $242M | $206M | $231M | $212M | $165M | $118M | $136M | $131M | |
| Cost of Revenue | $28M | $25M | $26M | $22M | $21M | $20M | $22M | $19M | $18M | $23M | $18M | $15M | $7M | $2M | $2M | $2M | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $213M | $197M | $158M | $117M | $134M | $129M | |
| R&D Expense | $82M | $77M | $85M | $88M | $78M | $78M | $101M | $67M | $76M | $60M | $67M | $157M | $59M | $69M | $76M | $81M | |
| SG&A Expense | $160M | $171M | $156M | $133M | $134M | $126M | $130M | $133M | $117M | $108M | $111M | $98M | $96M | $101M | $104M | $78M | |
| Operating Expenses | $270M | $273M | $267M | $243M | $232M | $225M | $106M | $219M | $212M | $191M | $196M | $269M | $162M | $172M | $183M | $162M | |
| Operating Income | $38M | $-5M | $17M | $36M | $32M | $19M | $154M | $32M | $30M | $15M | $35M | $-58M | $3M | $-54M | $-46M | $-31M | |
| Other Non-op | $647.0K | $542.0K | $596.0K | $593.0K | $594.0K | $588.0K | $575.0K | $576.0K | $386.0K | $286.0K | $0 | $2M | $-1M | $5M | $2M | $2M | |
| Pretax Income | $46M | $4M | $26M | $45M | $40M | $28M | $161M | $39M | $37M | $21M | $40M | $-52M | $6M | $-45M | $-41M | $-26M | |
| Income Tax | $15M | $344.0K | $-247M | $-27M | $14M | $9M | $17M | $6M | $4M | $4M | $-6M | $13M | $5M | $-2M | $835.0K | $768.0K | |
| Net Income | $32M | $4M | $274M | $72M | $27M | $19M | $144M | $33M | $33M | $17M | $46M | $-65M | $1M | $-43M | $-42M | $-27M | |
| EPS (Basic) | $0.18 | $0.02 | $1.62 | $0.43 | $0.16 | $0.11 | $0.87 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| EPS (Diluted) | $0.18 | $0.02 | $1.61 | $0.42 | $0.16 | $0.11 | $0.86 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| Shares (Basic) | 171,603,000 | 170,517,000 | · | 168,836,000 | 167,827,000 | 166,808,000 | · | 165,974,000 | 165,551,000 | 164,798,000 | · | 164,234,000 | 163,458,000 | 162,263,000 | · | 161,852 | |
| Shares (Diluted) | 172,851,000 | 172,706,000 | · | 170,650,000 | 168,681,000 | 167,668,000 | · | 166,178,000 | 166,174,000 | 166,623,000 | · | 164,234,000 | 165,046,000 | 162,263,000 | · | 161,852 | |
| EBITDA | $38M | $-5M | · | $36M | $32M | $19M | · | $32M | $30M | $15M | · | $-58M | $3M | $-54M | · | $-31M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $385M | $282M | $178M | $258M | $254M | $218M | $320M | $155M | $177M | $205M | $189M | $98M | $108M | $291M | $115M | $155M | |
| Receivables | $151M | $135M | $121M | $116M | $108M | $106M | $99M | $98M | $104M | $95M | · | $93M | $82M | $66M | · | $56M | |
| Inventory | $109M | $112M | $111M | $106M | $111M | $103M | $92M | $87M | $86M | $67M | · | $25M | $14M | $11M | · | $12M | |
| Prepaid Expense | $69M | $65M | $60M | $61M | $53M | $53M | $56M | $52M | $46M | $43M | · | $38M | $24M | $24M | · | $23M | |
| Current Assets | $1.22B | $1.10B | $1.06B | $1.08B | $961M | $871M | $938M | $788M | $729M | $675M | · | $499M | $493M | $503M | · | $522M | |
| PP&E (Net) | $17M | $15M | $8M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | · | $5M | $5M | $6M | · | $7M | |
| PP&E (Gross) | · | · | $17M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $10M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $103M | $106M | $109M | $112M | $114M | $117M | $120M | $106M | $108M | $110M | · | $67M | $68M | $70M | · | · | |
| Other Non-current Assets | $4M | $4M | $4M | $3M | $2M | $1M | $359.0K | $359.0K | $476.0K | $476.0K | · | $475.0K | $11M | $12M | · | $6M | |
| Total Assets | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Accounts Payable | $45M | $12M | $11M | $22M | $20M | $18M | $16M | $19M | $20M | $19M | · | $12M | $19M | $17M | · | $10M | |
| Accrued Liabilities | $317M | $293M | $266M | $335M | $310M | $284M | $379M | $325M | $318M | $311M | · | $197M | $169M | $207M | · | $107M | |
| Current Liabilities | $361M | $306M | $277M | $357M | $330M | $303M | $395M | $344M | $338M | $331M | · | $210M | $188M | $224M | · | $117M | |
| Capital Leases | $60M | $39M | $41M | $43M | $45M | $45M | $42M | $40M | $47M | $49M | · | $48M | $50M | $51M | · | $54M | |
| Deferred Tax | · | · | $11M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $15M | $13M | $19M | $14M | $29M | $20M | $18M | $15M | $12M | $11M | · | $13M | $9M | $5M | · | $6M | |
| Total Liabilities | $436M | $357M | $337M | $413M | $403M | $367M | $455M | $400M | $397M | $391M | · | $270M | $247M | $281M | · | $177M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | · | $16.0K | $16.0K | $16.0K | · | $16.0K | |
| Retained Earnings | $-1.78B | $-1.81B | $-1.81B | $-2.09B | $-2.16B | $-2.19B | $-2.20B | $-2.35B | $-2.38B | $-2.41B | · | $-2.48B | $-2.41B | $-2.41B | · | $-2.33B | |
| AOCI | $-958.0K | $-563.0K | $1M | $989.0K | $406.0K | $437.0K | $292.0K | $858.0K | $-339.0K | $-229.0K | · | $-319.0K | $-535.0K | $-220.0K | · | $-1M | |
| Stockholders' Equity | $1.31B | $1.25B | $1.23B | $917M | $822M | $765M | $733M | $577M | $517M | $464M | $432M | $362M | $396M | $374M | $400M | $426M | |
| Liabilities + Equity | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Shares Outstanding | 172,132,442 | 171,086,205 | 170,309,376 | 169,146,043 | 168,607,881 | 167,116,045 | 166,708,856 | 166,351,715 | 165,853,301 | 164,959,736 | · | 163,968,949 | 163,355,787 | 162,384,178 | · | 161,871,806 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $17M | $15M | $13M | $13M | $14M | $11M | $10M | $26M | $16M | $15M | $18M | $19M | $15M | $15M | $14M | $18M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $2M | $2M | $5M | $1M | $1M | $1M | $0 | $0 | $0 | |
| Operating Cash Flow | $101M | $34M | $-49M | $74M | $64M | $20M | $40M | $63M | $25M | $29M | $85M | $-59M | $8M | $-18M | $-24M | $-727.0K | |
| CapEx | $5M | $5M | $4M | $388.0K | $297.0K | $0 | $453.0K | $70.0K | · | · | $0 | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-9M | $66M | $-56M | $-79M | $-43M | $-124M | $122M | $-82M | $-56M | $-14M | $-347.0K | $34M | $-194M | $193M | $-18M | $15M | |
| Stock Issued | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Stock Activity | · | $4M | · | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Change in Cash | $103M | $105M | $-82M | $4M | $37M | $-102M | $164M | $-19M | $-28M | $16M | $90M | $-12M | $-181M | $176M | $-40M | $15M | |
| Free Cash Flow | · | $29M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| Net Margin | 10.2% | 1.4% | · | 25.8% | 10.1% | 7.8% | · | 13.1% | 13.8% | 8.0% | · | -30.8% | 0.67% | -36.3% | · | -20.8% | |
| Pretax Margin | 15.1% | 1.5% | · | 16.0% | 15.2% | 11.4% | · | 15.5% | 15.4% | 10.2% | · | -24.6% | 3.8% | -37.9% | · | -20.2% | |
| EBITDA Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| ROA | 2.1% | 0.27% | · | 6.2% | 2.5% | 1.9% | · | 4.1% | 4.3% | 2.2% | · | -10.5% | 0.18% | -6.7% | · | -4.1% | |
| ROE | 3.0% | 0.36% | · | 9.6% | 4.0% | 3.1% | · | 7.0% | 7.3% | 4.0% | · | -16.6% | 0.27% | -10.5% | · | -5.5% | |
| ROIC | 2.0% | -0.34% | · | 6.3% | 2.6% | 1.7% | · | 4.6% | 5.3% | 2.6% | · | -19.9% | 0.13% | -13.7% | · | -7.5% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 3.6 | · | 3.0 | 2.9 | 2.9 | · | 2.3 | 2.2 | 2.0 | · | 2.4 | 2.6 | 2.2 | · | 4.5 | |
| Quick Ratio | 1.5 | 1.4 | · | 1.0 | 1.1 | 1.1 | · | 0.7 | 0.8 | 0.9 | · | 0.9 | 1.0 | 1.6 | · | 1.8 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.6 | · | 0.8 | 0.6 | 0.1 | · | 0.2 | |
| Receivables Turnover | 2.4 | 2.2 | · | 2.6 | 2.5 | 2.4 | · | 2.6 | 2.6 | 2.6 | · | 2.9 | 2.2 | 1.8 | · | 2.2 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.59 | $7.29 | · | $5.42 | $4.88 | $4.58 | · | $3.47 | $3.12 | $2.81 | · | $2.21 | $2.42 | $2.30 | · | $2.63 | |
| Revenue / Share | $1.78 | $1.55 | · | $1.63 | $1.57 | $1.46 | · | $1.51 | $1.46 | $1.24 | · | $1289.01 | $1001.15 | $0.73 | · | $807.61 | |
| Cash Flow / Share | · | $0.20 | · | · | · | $0.12 | · | · | · | $0.17 | · | · | · | $-0.11 | · | · | |
| Cash / Share | $2.24 | $1.65 | · | $1.53 | $1.50 | $1.30 | · | $0.93 | $1.07 | $1.24 | · | $0.60 | $0.66 | $1.79 | · | $0.96 | |
| EPS (TTM) | $2.23 | $2.21 | · | $1.55 | $1.33 | $1.37 | · | $0.79 | $0.19 | $0.00 | · | $-0.92 | $-0.69 | $-0.91 | · | $-1.35 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.14B | $1.10B | · | $1.05B | $1.02B | $996M | · | $929M | $891M | $814M | · | $632M | $551M | $520M | · | $512M | |
| Net Income TTM | $380M | $376M | · | $261M | $222M | $229M | · | $129M | $31M | $-2M | · | $-149M | $-111M | $-146M | · | $-217M | |
| Market Cap | $4.35B | $3.81B | · | $3.61B | $3.64B | $2.78B | · | $2.56B | $2.70B | $3.05B | · | $3.42B | $3.91B | $3.06B | · | $2.65B | |
| P/E | 11.3 | 10.1 | · | 13.8 | 16.2 | 12.1 | · | 19.5 | 85.5 | · | · | -22.7 | -34.7 | -20.7 | · | -12.1 | |
| P/S | 3.8 | 3.5 | · | 3.4 | 3.6 | 2.8 | · | 2.8 | 3.0 | 3.7 | · | 5.4 | 7.1 | 5.9 | · | 5.2 | |
| P/B | 3.3 | 3.1 | · | 3.9 | 4.4 | 3.6 | · | 4.4 | 5.2 | 6.6 | · | 9.4 | 9.9 | 8.2 | · | 6.2 | |
| P / Tangible Book | 3.6 | 3.3 | · | 4.5 | 5.1 | 4.3 | · | 5.4 | 6.6 | 8.6 | · | 11.6 | 11.9 | 10.0 | · | 6.2 | |
| P / Cash Flow | · | 112.1 | · | · | · | 136.6 | · | · | · | 104.9 | · | · | · | -170.4 | · | · | |
| Earnings Yield | 8.8% | 9.9% | · | 7.3% | 6.2% | 8.2% | · | 5.1% | 1.2% | 0.00% | · | -4.4% | -2.9% | -4.8% | · | -8.2% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $1.07B | $958M | $726M | $517M | $484M |
| सकल मार्जिन % | · | · | 94.3% | 98.0% | 97.8% |
| परिचालन मार्जिन % | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% |
| शुद्ध आय | $391M | $226M | $-61M | $-216M | $-168M |
| तनुकरणित EPS | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 |
| त्वरित अनुपात | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $105M | $157M | $17M | $-114M | $-127M |
संस्थागत मालिक (13F) 385 फाइलर्स · $4.7B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
385
धारित मूल्य
$4.7B
नई स्थितियाँ
49
बाहर निकली पोजीशन
36
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 49 (-4 पिछली तिमाही की तुलना में) | 36 (+8 पिछली तिमाही की तुलना में) | 135 (+15 पिछली तिमाही की तुलना में) | 115 (-7 पिछली तिमाही की तुलना में) | +4.6M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $1085696471 | 42912904 | 23.31% | शेयर |
| BlackRock, Inc. | $569633876 | 22515173 | 12.23% | शेयर |
| VANGUARD GROUP INC | $404762192 | 15153957 | 8.69% | शेयर |
| STATE STREET CORP | $229628164 | 9076212 | 4.93% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $223612785 | 8838450 | 4.80% | शेयर |
| RTW INVESTMENTS, LP | $180756457 | 7144524 | 3.88% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $145822875 | 5763750 | 3.13% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $93482749 | 3694988 | 2.01% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $84977229 | 3358129 | 1.82% | शेयर |
| Palo Alto Investors LP | $72461629 | 2864096 | 1.56% | शेयर |
| GOLDMAN SACHS GROUP INC | $65276910 | 2580115 | 1.40% | शेयर |
| Qube Research & Technologies Ltd | $61899233 | 2446610 | 1.33% | शेयर |
| Point72 Asset Management, L.P. | $61559150 | 2433168 | 1.32% | शेयर |
| CITADEL ADVISORS LLC | $55209078 | 2182177 | 1.19% | शेयर |
| Pictet Asset Management Holding SA | $50146450 | 1983198 | 1.08% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $49826959 | 1969445 | 1.07% | शेयर |
| MARSHALL WACE, LLP | $44650402 | 1764838 | 0.96% | शेयर |
| D. E. Shaw & Co., Inc. | $42957806 | 1697937 | 0.92% | शेयर |
| BRAIDWELL LP | $41653895 | 1646399 | 0.89% | शेयर |
| NORGES BANK | $41069692 | 1623308 | 0.88% | शेयर |
| Frazier Life Sciences Management, L.P. | $36386409 | 1438198 | 0.78% | शेयर |
| NORTHERN TRUST CORP | $34595776 | 1367422 | 0.74% | शेयर |
| Nuveen, LLC | $34109259 | 1348192 | 0.73% | शेयर |
| Artisan Partners Limited Partnership | $33525890 | 1325134 | 0.72% | शेयर |
| BANK OF AMERICA CORP /DE/ | $32899740 | 1300385 | 0.71% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $32449679 | 1282596 | 0.70% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30520301 | 1206336 | 0.66% | शेयर |
| Allspring Global Investments Holdings, LLC | $28540663 | 1132566 | 0.61% | शेयर |
| Rockefeller Capital Management L.P. | $25690127 | 1015420 | 0.55% | शेयर |
| MORGAN STANLEY | $23949976 | 946639 | 0.51% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $23452898 | 926992 | 0.50% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $23082961 | 912370 | 0.50% | शेयर |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $21642506 | 855435 | 0.46% | शेयर |
| Invesco Ltd. | $20504689 | 810462 | 0.44% | शेयर |
| PRINCIPAL FINANCIAL GROUP INC | $19966658 | 789196 | 0.43% | शेयर |
| Bank of New York Mellon Corp | $19243919 | 760629 | 0.41% | शेयर |
| Allianz Asset Management GmbH | $19157034 | 757195 | 0.41% | शेयर |
| PANAGORA ASSET MANAGEMENT INC | $17985922 | 710906 | 0.39% | शेयर |
| Fisher Asset Management, LLC | $17690535 | 699230 | 0.38% | शेयर |
| FRED ALGER MANAGEMENT, LLC | $16409858 | 648611 | 0.35% | शेयर |
| RICE HALL JAMES & ASSOCIATES, LLC | $15657841 | 618887 | 0.34% | शेयर |
| AMERIPRISE FINANCIAL INC | $15348144 | 606536 | 0.33% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $14925077 | 589924 | 0.32% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $14771456 | 583852 | 0.32% | शेयर |
| AQR CAPITAL MANAGEMENT LLC | $13225551 | 522749 | 0.28% | शेयर |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12903000 | 510000 | 0.28% | शेयर |
| GLENMEDE TRUST CO NA | $12360212 | 488546 | 0.27% | शेयर |
| Hudson Bay Capital Management LP | $11764500 | 465000 | 0.25% | शेयर |
| UBS Group AG | $11639341 | 460053 | 0.25% | शेयर |
| JUPITER ASSET MANAGEMENT LTD | $11599190 | 458466 | 0.25% | शेयर |
कार्यकर्ता और 5%+ मालिक 6 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB3 LLC ×14 फाइलिंग | 26 फ़रवरी 2026 | 25.40% | संशोधन | · | SEC |
| Baker Bros. Advisors, LLC, Felix J. Baker, Julian C. Baker ×4 फाइलिंग | 6 जून 2013 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 2 मई 2005 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 2 मई 2005 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 2 मई 2005 | · | प्रारंभिक फाइलिंग | · | SEC |
| Oxford Bioscience Partners IV L.P., mRNA Fund II L.P., OBP Management IV L.P., Jeffrey T. Barnes, Mark P. Carthy, Jonathan J. Fleming, Michael E. Lytton, Alan G. Walton | 29 अप्रैल 2005 | · | प्रारंभिक फाइलिंग | निष्क्रिय निवेश | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 42 इनसाइडर्स · 24 अधिकारी · 21 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Adams Catherine Owen | Chief Executive Officer | 24 मार्च 2026 M | 14803 | 0 | 1 | $-249932 |
| Stephen Davis | CEO | 19 अगस्त 2024 S | 186555 | 0 | 0 | $0 |
| Uli Hacksell | CEO | 17 फ़रवरी 2015 M | 115549 | 0 | 0 | $0 |
| Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | 6 अगस्त 2026 M | 67828 | 0 | 9 | $-1126027 |
| Elena Ridloff | EVP and CFO | 29 अप्रैल 2021 M | 10553 | 0 | 0 | $0 |
| Todd S. Young | EVP AND CFO | 15 अक्टूबर 2018 A | · | 0 | 0 | $0 |
| Thomas H Aasen | EXEC VP, CFO AND CBO | 4 अप्रैल 2014 M | 0 | 0 | 0 | $0 |
| Srdjan R. Stankovic | President | 21 नवमबर 2022 M | 61234 | 0 | 0 | $0 |
| Mark R Brann | President & CSO | 16 जून 2006 S | 317756 | 0 | 0 | $0 |
| Brendan Teehan | EVP, COO, HEAD OF COMMERCIAL | 17 नवमबर 2024 M | 62105 | 0 | 0 | $0 |
| Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | 29 जुलाई 2026 M | 18994 | 0 | 3 | $-506411 |
| James Kihara | PRINCIPAL ACCOUNTING OFFICER | 26 जून 2026 S | 13088 | 0 | 8 | $-602789 |
| Jennifer J Rhodes | EVP, CHIEF LEGAL OFFICER, SEC | 24 मार्च 2026 M | 11280 | 0 | 2 | $-245022 |
| Thomas Garner | EVP, Chief Commercial Officer | 6 मार्च 2026 A | · | 0 | 0 | $0 |
| Austin D. Kim | EVP,General Counsel, Secretary | 6 जनवरी 2024 M | 46901 | 0 | 0 | $0 |
| Douglas J Williamson | Executive VP, Research & Dev | 10 फ़रवरी 2023 A | · | 0 | 0 | $0 |
| Michael J. Yang | EVP and CCO | 6 जनवरी 2021 M | 8059 | 0 | 0 | $0 |
| Eric Alejandro Miller | Controller & PAO | 15 अक्टूबर 2019 M | 270 | 0 | 0 | $0 |
| Glenn Baity | EVP AND GC | 18 अप्रैल 2018 A | 83734 | 0 | 0 | $0 |
| Terrence O Moore | EVP, CHIEF COMMERCIAL OFFICER | 8 मार्च 2017 A | 1671 | 0 | 0 | $0 |
| Roger Mills | EVP, DEVELOPMENT AND CMO | 20 मार्च 2015 A | 18550 | 0 | 0 | $0 |
| Bo-Ragnar Tolf | VP/Mg. Dir. ACADIA Pharma AB | 8 जुलाई 2009 M | 20000 | 0 | 0 | $0 |
| Brian Lundstrom | Sr. VP, Bus. Development | 7 मार्च 2008 A | 0 | 0 | 0 | $0 |
| Robert E Davis | Exec. VP, Drug Discovery | 11 मार्च 2005 A | · | 0 | 0 | $0 |
| Adora Ndu | निदेशक | 29 मई 2026 A | 32908 | 0 | 0 | $0 |
| Elizabeth A. Garofalo | निदेशक | 29 मई 2026 A | 33489 | 0 | 0 | $0 |
| Jonathan Poole | निदेशक | 29 मई 2026 A | 2010 | 0 | 0 | $0 |
| James M Daly | निदेशक | 29 मई 2026 A | 12148 | 0 | 1 | $-671100 |
| Laura Brege | निदेशक | 29 मई 2026 A | 23202 | 0 | 0 | $0 |
| Edmund Harrigan | निदेशक | 29 मई 2026 A | 43148 | 0 | 0 | $0 |
| Daniel B Soland | निदेशक | 29 मई 2025 A | 44041 | 0 | 0 | $0 |
| Mary Ann Gray | निदेशक | 7 जून 2016 M | 149476 | 0 | 0 | $0 |
| Leslie L Iversen | निदेशक | 18 अप्रैल 2016 M | 36127 | 0 | 0 | $0 |
| Lester J Ph D Kaplan | निदेशक | 11 अगस्त 2015 M | 17000 | 0 | 0 | $0 |
| William Mcdowall Wells | निदेशक | 15 जून 2015 A | 0 | 0 | 0 | $0 |
| Torsten Rasmussen | निदेशक | 15 जून 2015 A | 8500 | 0 | 0 | $0 |
| Michael T Borer | निदेशक | 15 जून 2015 A | 0 | 0 | 0 | $0 |
| Gordon M Binder | निदेशक | 12 जून 2009 A | 14364 | 0 | 0 | $0 |
| Alan G Walton | निदेशक | 12 जून 2009 A | 25979 | 0 | 0 | $0 |
| Martien Van Osch | निदेशक | 10 जून 2005 A | 1168892 | 0 | 0 | $0 |
| GORDON CARL L | निदेशक | 20 अप्रैल 2005 A | 774006 | 0 | 0 | $0 |
| John Joseph Kaiser | · | 20 अक्टूबर 2008 A | · | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 59 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IBRN · iShares Trust | 4.92% | 13265 SH | 11 सितमबर 2026 | दैनिक |
| PBE · Invesco Exchange-Traded Fund Trust | 1.84% | 383853 SH | 2 अक्टूबर 2026 | दैनिक |
| BBP · ETFis Series Trust I | 1.69% | 64350 NS | 31 जुलाई 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1.40% | 122788 SH | 2 अक्टूबर 2026 | दैनिक |
| RZG · Invesco Exchange-Traded Fund Trust | 0.96% | 57480 SH | 2 अक्टूबर 2026 | दैनिक |
| LABU · Direxion Shares ETF Trust | 0.71% | 134777 NS | 31 जुलाई 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0.62% | 14725 NS | 31 जुलाई 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.35% | 150827 SH | 19 अगस्त 2026 | दैनिक |
| IBB · iShares Trust | 0.35% | 1293913 SH | 11 सितमबर 2026 | दैनिक |
| IWO · iShares Trust | 0.24% | 1215092 SH | 11 सितमबर 2026 | दैनिक |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.23% | 12181 SH | 2 अक्टूबर 2026 | दैनिक |
| PWS · Pacer Funds Trust | 0.20% | 1841 NS | 31 जुलाई 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.19% | 137860 SH | 19 अगस्त 2026 | दैनिक |
| BKSE · BNY Mellon ETF Trust | 0.19% | 6256 NS | 31 जुलाई 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.17% | 443221 SH | 19 अगस्त 2026 | दैनिक |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.17% | 19976 SH | 2 अक्टूबर 2026 | दैनिक |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.16% | 36279 NS | 31 जुलाई 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.13% | 34493 NS | 31 जुलाई 2026 | N-PORT |
| IWM · iShares Trust | 0.12% | 3296450 SH | 11 सितमबर 2026 | दैनिक |
| ISCG · iShares Trust | 0.12% | 40348 SH | 11 सितमबर 2026 | दैनिक |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.10% | 137841 SH | 2 अक्टूबर 2026 | दैनिक |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.10% | 741237 SH | 19 अगस्त 2026 | दैनिक |
| DFAS · Dimensional ETF Trust | 0.09% | 559090 NS | 31 जुलाई 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.09% | 1699377 SH | 19 अगस्त 2026 | दैनिक |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.08% | 40712 NS | 31 जुलाई 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.05% | 52513 SH | 2 अक्टूबर 2026 | दैनिक |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.05% | 10893 NS | 31 जुलाई 2026 | N-PORT |
| SMDX · Tidal Trust III | 0.05% | 2295 NS | 31 जुलाई 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 54681 NS | 31 जुलाई 2026 | N-PORT |
| IEUS · iShares Trust | 0.04% | 7263 SH | 11 सितमबर 2026 | दैनिक |
| VXF · VANGUARD INDEX FUNDS | 0.04% | 1457036 SH | 19 अगस्त 2026 | दैनिक |
| VB · VANGUARD INDEX FUNDS | 0.04% | 2944095 SH | 19 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.04% | 346329 SH | 19 अगस्त 2026 | दैनिक |
| PDN · Invesco Exchange-Traded Fund Trust … | 0.04% | 13154 SH | 2 अक्टूबर 2026 | दैनिक |
| WSML · iShares Trust | 0.04% | 11751 SH | 11 सितमबर 2026 | दैनिक |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.03% | 4009 SH | 2 अक्टूबर 2026 | दैनिक |
| DXUV · Dimensional ETF Trust | 0.02% | 5018 NS | 31 जुलाई 2026 | N-PORT |
| ISCF · iShares Trust | 0.02% | 13099 SH | 11 सितमबर 2026 | दैनिक |
| DFUV · Dimensional ETF Trust | 0.02% | 113182 NS | 31 जुलाई 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.02% | 348929 NS | 31 जुलाई 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.02% | 103974 NS | 31 जुलाई 2026 | N-PORT |
| SCZ · iShares Trust | 0.02% | 238968 SH | 9 सितमबर 2026 | दैनिक |
| DCOR · Dimensional ETF Trust | 0.01% | 16150 NS | 31 जुलाई 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0.01% | 28150 SH | 19 अगस्त 2026 | दैनिक |
| DFAU · Dimensional ETF Trust | 0.01% | 39121 NS | 31 जुलाई 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 35516 SH | 10 सितमबर 2026 | दैनिक |
| ITOT · iShares Trust | 0.00% | 161527 SH | 11 सितमबर 2026 | दैनिक |
| DFUS · Dimensional ETF Trust | 0.00% | 35634 NS | 31 जुलाई 2026 | N-PORT |
| IEFA · iShares Trust | 0.00% | 240578 SH | 11 सितमबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.00% | 632 NS | 31 जुलाई 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4075731 SH | 19 अगस्त 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 100076 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 10781 SH | 19 अगस्त 2026 | दैनिक |
| IJR · iShares Trust | · | 7728763 SH | 10 सितमबर 2026 | दैनिक |
| IJT · iShares Trust | · | 1198794 SH | 9 सितमबर 2026 | दैनिक |
| XJR · iShares Trust | · | 17544 SH | 31 अगस्त 2026 | दैनिक |
| ISCB · iShares Trust | · | 5636 SH | 11 सितमबर 2026 | दैनिक |
| SMLF · iShares Trust | · | 221806 SH | 11 सितमबर 2026 | दैनिक |
| SMMV · iShares Trust | · | 16924 SH | 19 अगस्त 2026 | दैनिक |
ACAD विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 27 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$33.00
+65.4%
7 25.9%
मजबूत खरीद
14 51.9%
खरीदें
5 18.5%
होल्ड
1 3.7%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
19 विश्लेषक · 2026-09-29माध्य लक्ष्य $32.16 +61.2%
अभी
वर्तमान मूल्य $19.95
निम्न$17.00
माध्य$32.16
उच्च$49.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
BLUECHIP_DIP
समाप्त
जोखिम 1
पुरस्कार 5.00
प्रवेश
$21.20
R:R 5.00
BLUECHIP_DIP
स्टॉप आउट
जोखिम 1
पुरस्कार 4.79
प्रवेश
$21.86
R:R 4.79
BLUECHIP_DIP
स्टॉप आउट
जोखिम 1
पुरस्कार 4.99
प्रवेश
$22.45
R:R 4.99
अभी कोई खुला सिग्नल नहीं — कोई कार्ड भरा नहीं है, और यह ईमानदार है।
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q अग 5, 2026 को फाइल किया गया